Cargando…
Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary tumor of the liver. To further define its clinicopathology and surgical management, we reviewed our experience. Clinical presentations of 32 patients with ICC was similar to that with hepatocellular carcinoma. Jaundice occurred...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442948/ https://www.ncbi.nlm.nih.gov/pubmed/1319194 http://dx.doi.org/10.1155/1992/93976 |
_version_ | 1782156748774178816 |
---|---|
author | Schlinkert, Richard T. Nagorney, David M. van Heerden, Jon A. Adson, Martin A. |
author_facet | Schlinkert, Richard T. Nagorney, David M. van Heerden, Jon A. Adson, Martin A. |
author_sort | Schlinkert, Richard T. |
collection | PubMed |
description | Intrahepatic cholangiocarcinoma (ICC) is the second most common primary tumor of the liver. To further define its clinicopathology and surgical management, we reviewed our experience. Clinical presentations of 32 patients with ICC was similar to that with hepatocellular carcinoma. Jaundice occurred in only 27 percent. ICC was unresectable due to advanced disease stage in 81 percent. Six patients had curative resections with two 5 year disease free survivors. Underlying liver disease was associated with ICC in 34 percent of patients. |
format | Text |
id | pubmed-2442948 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1992 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-24429482008-07-08 Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment Schlinkert, Richard T. Nagorney, David M. van Heerden, Jon A. Adson, Martin A. HPB Surg Research Article Intrahepatic cholangiocarcinoma (ICC) is the second most common primary tumor of the liver. To further define its clinicopathology and surgical management, we reviewed our experience. Clinical presentations of 32 patients with ICC was similar to that with hepatocellular carcinoma. Jaundice occurred in only 27 percent. ICC was unresectable due to advanced disease stage in 81 percent. Six patients had curative resections with two 5 year disease free survivors. Underlying liver disease was associated with ICC in 34 percent of patients. Hindawi Publishing Corporation 1992 /pmc/articles/PMC2442948/ /pubmed/1319194 http://dx.doi.org/10.1155/1992/93976 Text en Copyright © 1992 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Schlinkert, Richard T. Nagorney, David M. van Heerden, Jon A. Adson, Martin A. Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment |
title | Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment |
title_full | Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment |
title_fullStr | Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment |
title_full_unstemmed | Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment |
title_short | Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment |
title_sort | intrahepatic cholangiocarcinoma: clinical aspects, pathology and treatment |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442948/ https://www.ncbi.nlm.nih.gov/pubmed/1319194 http://dx.doi.org/10.1155/1992/93976 |
work_keys_str_mv | AT schlinkertrichardt intrahepaticcholangiocarcinomaclinicalaspectspathologyandtreatment AT nagorneydavidm intrahepaticcholangiocarcinomaclinicalaspectspathologyandtreatment AT vanheerdenjona intrahepaticcholangiocarcinomaclinicalaspectspathologyandtreatment AT adsonmartina intrahepaticcholangiocarcinomaclinicalaspectspathologyandtreatment |